<DOC>
	<DOCNO>NCT02990793</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy individualize , Biometrics-guided Magnetic e-Resonance Therapy ( MeRT ) treatment Persistent Post-Concussive Symptoms ( PPCS ) follow Traumatic Brain Injury ( TBI ) .</brief_summary>
	<brief_title>Clinical Trial Evaluate Safety Efficacy MeRT Treatment Persistent Post-Concussive Symptoms ( PPCS )</brief_title>
	<detailed_description>MeRT-TBI-005 prospective , double blind , randomize , sham-controlled , parallel group , adaptive clinical trial design evaluate efficacy EEG/EKG-guided MeRT active duty military service men woman , reservist active duty order , military retiree Persistent Post-Concussion Symptoms ( PPCS ) Traumatic Brain Injury . A total 150 participant randomize , blind adaptive sample size reassessment 250 participant , contingent group-sequential single look interim efficacy data Data Safety Monitoring Board ( DSMB ) . Participants recruit military base , vicinity , two location . Eligible participant randomly assign either MeRT Sham MeRT treatment group 1:1 allocation ratio , stratification recruitment site two level PTSD co-morbidity ( +/- ) . Treatment initiated Day 1 study , follow eligibility evaluation data collection Screening Visit ( SC ) Baseline ( BL ) Visit . Following SC BL visit , 4-week treatment period . Main study outcomes collected second follow-up visit ( F2 ) conclusion 4-week treatment period . An abbreviated data collection visit occur conclusion second treatment week ( F1 follow-up visit ) . Participants , clinician , personnel participate evaluation , interface treatment protocol download software , blind study treatment group assignment .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Post-Concussion Syndrome</mesh_term>
	<criteria>Participants must meet follow inclusion criterion qualify enrollment study : 1 . Active duty , reservist active duty order , military retiree , United States military service 2 . Age 18 55 year 3 . TBI accord follow American Congress Rehabilitation Medicine ( ACRM ) criterion mTBI , except severity injury associate focal neurological deficit ( ) may exceed ACRM criterion mild injury : Sustaining traumatically induce physiological disruption brain function , manifest least one follow Any period loss consciousness Any loss memory event immediately accident Any alteration mental state time accident Focal neurological deficit ( ) may may transient 4 . The TBI follow within maximum 4 week symptoms least 3 follow 6 category list ICD10 criterion PostConcussive syndrome : Headache , dizziness , malaise , fatigue , noise tolerance Irritability , depression , anxiety , emotional lability Subjective concentration , memory , intellectual difficulty without neuropsychological evidence mark impairment Insomnia Reduced alcohol tolerance Preoccupation symptom fear brain damage hypochondriacal concern adoption sick role 5 . Symptoms least 3 6 PostConcussive symptom category list persist least 6 month Screening Visit 6 . Rivermead PostConcussion Questionnaire ( RPQ16 ) score â‰¥ 30 7 . No plan move away area , knowledge deployment , prior 5 week 3 day day Baseline Visit 8 . Willing able adhere study treatment data collection schedule study procedures Participants exclude study participation one follow exclusion criterion apply : 1 . History open skull injury 2 . History neurological disorder include , limited : Seizure disorder Any condition likely associate increase intracranial pressure Space occupy brain lesion 3 . History cerebrovascular accident 4 . History cerebral aneurysm 5 . EEG abnormalities indicate risk seizure , i.e. , abnormal focal general slowing , ictal spike , EEG record 6 . Participation interventional research protocol within 3 month prior Screening Visit 7 . History type ECT , MeRT , rTMS 8 . Treated within 30 day Screening Visit antipsychotic medication 9 . Treated within 30 day Screening Visit anticonvulsant anxiolytic medication list exclusionary protocol 10 . Intracranial implant ( e.g. , aneurysm clip , shunt , stimulators , cochlear implant , stent , electrode ) metal object within near head , exclude mouth , safely remove 11 . Implanted cardiac pacemaker , implantable cardioverter defibrillator ( ICD ) , medication dispense device 12 . Clinically significant abnormality clinically significant unstable medical condition Investigator 's judgment might pose potential safety risk participant 13 . Clinically significant medical illness condition , include , limited , uncontrolled thyroid disorder , hepatic , cardiac , pulmonary renal malfunction , chronic excessive alcohol consumption 14 . Clinically significant psychopathology , include , limited , schizophrenia bipolar disorder , psychiatric disorder Investigator 's judgment might pose potential safety risk participant limit interpretation trial result 15 . An elevated risk suicide violence others 16 . Current treatment Cognitive Behavioral Therapy ( CBT ) psychotherapeutic treatment stable precede 30 day time Screening Visit 17 . Current treatment medication regimen stable precede 30 day time Screening Visit 18 . Any condition , include inability communicate English , comply study procedure , judgment Investigator would prevent participant complete study 19 . Inability acquire satisfactory EEG/ECG Baseline , routine basis 20 . Pregnant , female unwilling use effective birth control course trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Concussion</keyword>
	<keyword>TBI</keyword>
	<keyword>TMS</keyword>
</DOC>